Variations within genes of the MAPK signaling pathway in TECs, such as amplifications in CDC42, HSPB1, NRAS, and deletions in AKT1, MAPK1, might reveal their significance in HCC, possibly related to their roles in tumor growth and progression, particularly in signaling pathways. The gene discussed is NRAS; the disease is hepatocellular carcinoma.